Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.

HYTN will endeavour to amend its licenses and/or certificates, establish a stability program, and implement GMP-compliant processes tailored for vape cartridge production.

Veeva Systems (NYSE: VEEV) and Zifo today announced a product partnership to help biopharmas modernize quality control (QC) ...

Stock Market LIVE Updates | Indian benchmark equity indices opened lower on Thursday, weighed down by FMCG stocks following ...

There are a host of new cars coming that you should be excited about, and we’ve put together a huge encyclopedia of all of the most significant right here.  This guide covers everything from small, ...

Sanofi (NASDAQ:SNY) has received EU regulatory approval for its drug Sarclisa for the treatment of newly diagnosed multiple myeloma patients. The drug was approved for use in combination with a ...